Work

Phase I Expansion and Pharmacodynamic Study of the Oral MEK Inhibitor RO4987655 (CH4987655) in Selected Patients with Advanced Cancer with RAS–RAF Mutations

Year: 2014
Type: article
Study design: Clinical Trial
Language: English
Open Access status: closed
OpenAlex ID: W2054913636
FWCI: 3.556
Cites: 49
Cited by: 79
Related to: 10